Point-Of-Care Molecular Diagnostics Industry Valued at $7.02 Billion by 2029 With CAGR of 15% | Size and Share Insights
Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.
What Is the Forecast for the Point-Of-Care Molecular Diagnostics Market from 2024 to 2025?
The market size of point-of-care molecular diagnostics has seen a significant rise recently. It is projected to escalate from $3.55 billion in 2024 to $4.01 billion in 2025, showcasing a compound annual growth rate (CAGR) of 12.9%. Factors contributing to the past growth include a surge in requirements for swift disease diagnosis, a rise in incidents of infectious diseases, the enlargement of telemedicine and distant testing, regulatory backing for point-of-care diagnostics, and the demand for customized and precision medicine.
What Is the Projected Market Size of the Point-Of-Care Molecular Diagnostics Market?
The market for point-of-care molecular diagnostics is projected to witness substantial growth in the upcoming years, swelling to a valuation of $7.02 billion in 2029 with a Compound Annual Growth Rate (CAGR) of 15.0%. Factors contributing to this anticipated rise during the forecast period includes the miniaturization of diagnostic devices, growing scope of point-of-care testing for cancer and genetic diseases, personalized molecular diagnostics for varying applications, the incorporation of artificial intelligence and machine learning for data examination, and growing awareness of emerging infectious diseases. Noteworthy trends for the predicted period consist of lab-on-a-chip and microfluidic technologies, smartphone-focused diagnostics and digital health, preparedness for point-of-care Covid-19 and other pandemics, predictive diagnostics powered by AI, and CRISPR-based molecular testing.
Download The Free Sample Report Here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=7046&type=smp
Who are the Major Competitors in the Point-Of-Care Molecular Diagnostics Market Outlook?
Major companies operating in the point-of-care molecular diagnostics market include Abbott Laboratories, F Hoffmann-La Roche Ltd., BioMérieux SA, Danaher Corporation, Quidel Corporation, BioMerieux SA, Bio-Rad Laboratories Inc., Sysmex Corporation, Illumina Inc., Myriad Genetics Inc., Siemens Healthcare GmbH, Almac Group, Biogenex Laboratories Inc., Cepheid Inc., Epic Sciences Inc., Foundation Medicine Inc., Genomic Health Inc., Grail Inc., Hologic Inc., HTG Molecular Diagnostics Inc., Inivata Ltd., Invivoscribe Inc., MolecularMD Corporation, Natera Inc., NeoGenomics Laboratories Inc., Personal Genome Diagnostics Inc., Prometheus Laboratories Inc., Ventana Medical Systems Inc., Vermillion Inc., Guardant Health Inc., Exact Sciences Corporation, Biocartis Group NV, ArcherDx Inc., Bio-Techne Corporation, AccuBiotech Co. Ltd., Becton, Dickinson and Company, Chembio Diagnostics Inc., Credo Diagnostics Biomedical Pvt. Ltd., EKF Diagnostics, GenePOC Inc.
What Is Fueling Growth in the Point-Of-Care Molecular Diagnostics Market?
The quick surge in infectious and respiratory diseases is anticipated to significantly influence the growth of the point-of-care molecular diagnostics market. Respiratory infections including bacteria or viruses are triggered by microorganisms impacting the respiratory system. These pathogens can be propagated through coughs, sneezes, or direct contact. The complexity of the respiratory medications encompasses a range of inhalers, oral medications, intravenous treatments, and point-of-care molecular diagnostic tools to treat the patient. For example, the Office for National Statistics, a recognized statistics institute in the UK, reported that in England at the end of the week concluding on December 9, 2022, the rate of infection spiked for individuals aged between 35 and 69, and also elevated for those in school years 12 to 24. Consequently, the swift rise of infectious and respiratory diseases will propel the point-of-care molecular diagnostics market.
Request For A Customized Report:
https://www.thebusinessresearchcompany.com/customise?id=7046&type=smp
Which Point-Of-Care Molecular Diagnostics Market Segments Are Growing the Fastest?
The point-of-care molecular diagnostics market covered in this report is segmented –
1) By Product And Service: Assays And Kits, Instruments And Analyzers, Software And Services
2) By Technology: Reverse Transcription – Polymerase Chain Reaction (RT-PCR), In Situ Hybridization, Sequencing
3) By Application: Respiratory Diseases, Hospital Acquired Infections (HAIs), Cancer/Oncology, Hepatitis, Hematology
4) By End-User: Decentralized Labs, Hospitals, Home Care, Assisted Living Healthcare Facilities
Subsegments:
1) By Assays And Kits: Nucleic Acid Amplification Tests (NAATs), Rapid Diagnostic Tests, Molecular Detection Kits, Reagents And Consumables
2) By Instruments And Analyzers: PCR Machines, Microfluidic Devices, Sequencers, Point-of-Care Analyzers
3) By Software And Services: Data Management Software, Cloud-Based Solutions, Technical Support And Maintenance Services, Consultation And Training Services
Which Industry Trends Are Shaping the Future of the Point-Of-Care Molecular Diagnostics Market?
The rise of technological innovation is a prominent trend in the point-of-care molecular diagnostics market. Leading companies in this market are strategically utilizing advanced technology to reinforce their market presence. They are deploying cutting-edge point-of-care molecular diagnostics technological solutions and related services such as enzyme-linked immunosorbent assay (ELISA), polymerase chain reaction (PCR), mass spectrometry (MS), situ hybridizations, spectral karyotyping imaging, DNA microarrays, and more. These technologies are incorporated into POC devices to speed up analysis times and reduce costs. An illustration of this trend occurred in May 2023, when US diagnostics company Sensible Diagnostics introduced a 10-minute point-of-care PCR system. The firm drew from its experience gained through the pandemic and has administered over two million molecular point-of-care COVID-19 tests. It’s PCR platform boasts a rapid 10-minute time-to-result.
Access The Full Report Here:
Which Countries Are Leading the Point-Of-Care Molecular Diagnostics Market?
North America was the largest region in the point-of-care molecular diagnostics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the point-of-care molecular diagnostics market report include Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
Purchase The Full Report Today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=7046
This Report Delivers Insight On:
1. How big is the point-of-care molecular diagnostics market, and how is it changing globally?
2. Who are the major companies in the point-of-care molecular diagnostics market, and how are they performing?
3. What are the key opportunities and risks in the point-of-care molecular diagnostics market right now?
4. Which products or customer segments are growing the most in the point-of-care molecular diagnostics market?
5. What factors are helping or slowing down the growth of the point-of-care molecular diagnostics market?
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
